
|Articles|February 6, 2006
States sue over Part D Rx costs
Advertisement
At least five states will appeal directly to the U.S. Supreme Court to block the federal government from billing them for millions of dollars for drugs for former Medicaid patients switched to Medicare Part D plans. Although Congress had assured states that the change would lower their drug costs by 10%, the states contend that a flaw in the financial formula is leading the federal government to overcharge them.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA-Approved Sunscreen Filter Bemotrizinol Debuts in New US Products
2
FDA Approves XFG-Targeted COVID-19 Vaccines From Multiple Companies
3
FDA Approves Stelara for Pediatric Ulcerative Colitis
4
COVID-19 in 2026: Why the Virus Still Threatens Vulnerable Patients
5




























